Literature DB >> 7935214

A superconducting cyclotron for neutron radiation therapy.

R L Maughan1, W E Powers, H G Blosser.   

Abstract

The physical and clinical specifications of a neutron therapy facility utilizing a superconducting cyclotron are presented. The cyclotron and its support system are described. Details of the operation of the cyclotron in a hospital environment are given; the requirements of the helium liquifier and cryogenic system are described together with a summary of its mode of operation. The simplicity of the cyclotron control system is discussed. The physical characteristics of the neutron beam are described. The central axis percent depth dose curve is equivalent to that of a 4 MV x-ray beam. The depth of maximum dose occurs at approximately 9 mm depth and the surface dose is between 40% and 45%. The multirod collimator allows for the production of irregularly shaped fields of size up to 26.5 x 30 cm, without excessive exposure to operating personnel.

Entities:  

Mesh:

Year:  1994        PMID: 7935214     DOI: 10.1118/1.597337

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  4 in total

1.  The cost-effectiveness of mixed beam neutron-photon radiation therapy in the treatment of adenocarcinoma of the prostate.

Authors:  R L Maughan; B Brambs; A T Porter; J D Forman
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Three dimensional conformal neutron radiotherapy for prostate cancer.

Authors:  P J Chuba; R Maughan; J D Forman
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

3.  Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment.

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; J.Edson Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

4.  Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer.

Authors:  Phillip J Taddei; Jonas D Fontenot; Yuanshui Zheng; Dragan Mirkovic; Andrew K Lee; Uwe Titt; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2008-03-27       Impact factor: 3.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.